It has been proposed that the deficit in β-cell mass in type 1 diabetes (T1D) may be due, in part, to β-cell degranulation to chromogranin-positive hormone-negative (CPHN) cells. The frequency and distribution of pancreatic CPHN cells were investigated in 19 children with T1D compared with 14 non-diabetic (ND) children. We further evaluated these cells for replication and expression of endocrine lineage markers Nkx6.1 and Nkx2.2, and compared these frequencies with those previously reported in CPHN cells in adults with T1D. In contrast to adults' cells, pancreatic CPHN cells were comparably abundant (percentage of endocrine cells ± standard error of the mean, 1.4 ± 0.2 vs 1.0 ± 0.2 in patients with T1D vs ND subjects, respectively; P = not significant) and comparably distributed in children with T1D vs ND donors. Replication of CPHN cells was detected but unchanged in children with T1D vs ND children, as was the percentage of CPHN cells expressing Nkx6.1 or NKx2.2. In children with T1D, the frequency of pancreatic CPHN cells was not increased, and this differed from adults with T1D.
comparable pattern and distribution of such cells in late gestation and early infancy in humans [10] .
There appears to be ongoing β-cell turnover in adults with longstanding T1D, although the source of these cells is unknown [11] [12] [13] . We previously examined pancreas tissue from adult brain-dead organ donors with T1D vs nondiabetic (ND) control subjects and found an increase in endocrine cells that did not express any known pancreatic hormone occurring in a distribution comparable to that in the developing human pancreas [14] . To determine whether the increased presence and scale of nonhormone-expressing endocrine cells in the pancreas differ in children with T1D, in whom the severity of the disease may be greater but in the setting of potentially greater plasticity in the pancreas, we investigated a cohort of children with T1D and age-and body mass index (BMI)-matched ND control subjects available through the outstanding repository of human pancreas assembled by the Network for Pancreatic Organ Donors with Diabetes (nPOD) consortium based at the University of Florida.
Using this resource, we investigated if is there an increase in the frequency of nonhormoneexpressing endocrine cells in the pancreas in children with T1D, and we examined the distribution of these cells within the pancreas in both groups of children. In normal late gestation and early infancy, nonhormone-expressing endocrine cells are most abundant as scattered foci in the exocrine pancreas and are believed to represent newly forming and differentiating pancreatic endocrine cells.
sampling of the entire pancreas organ while maintaining anatomic orientation. Because preparation is completed within 2 hours, tissue integrity is maintained. Tissues intended for paraffin blocks are trimmed to pieces no larger than 1.5 ×1.5 cm and fixed in 10% neutral buffered formalin for 24 ± 8 hours. Fixation is terminated by transfer to 70% ethanol, and samples are subsequently processed and embedded in paraffin. Mounted transverse sections from the paraffin-embedded tissue blocks were obtained from the body of the pancreas in most cases; where blocks of pancreas body were unavailable, sections from the head of the pancreas were used.
C. Immunostaining C-1. For assessment of presence and frequency of CPHN cells-All staining was performed at the University of California, Los Angeles. Paraffin tissue sections from each subject were stained for chromogranin A, insulin, glucagon, somatostatin, pancreatic polypeptide, and ghrelin. Standard immunohistochemistry protocol was used for fluorescent immunodetection of various proteins in pancreatic sections [14] .
Briefly, slides were incubated at 4°C overnight with a cocktail of primary antibodies prepared in antibody solution (3% bovine serum albumin in Slides were counterstained to mark the nuclei, using a mounting medium containing 4′,6-diamidino-2-phenylindole (Vectashield; Vector Laboratories, Burlingame, CA) and viewed using a Leica DM6000 microscope (Leica Microsystems, Deerfield, IL). Images were acquired using the ×20 objective (×200 magnification) using a Hamamatsu Orca-ER camera (catalog no. C4742-80-12AG; Indigo Scientific, Bridgewater, NJ) and Openlab software (Improvision, Lexington, MA). C-2. Assessment of potential endocrine lineage and frequency of replication of CPHN cells-To investigate the potential endocrine cell lineage of CPHN cells in children and adults with T1D, we evaluated Ki67 as a endocrine replication marker (mouse anti-Ki67, 1:50; RRID: AB_2142367; catalog no. M7240; Agilent Technologies), Nkx2.2 as a panendocrine transcription factor (mouse anti-Nkx2.2, 1:50; RRID: AB_531794; catalog no. 74.5A5; DHSB), and Nkx6.1 as a β-cell transcription factor (mouse anti-Nkx6.1, 1:300; RRID: AB_532378; catalog no. F55A10; DSHB) using, in each case, a secondary antibody conjugated to Cy3 (RRID: AB_2340813). We combined this evaluation with a cocktail of all known pancreatic hormones, as described previously [11, 14] [14] . Slides were counterstained to mark the nuclei using a mounting medium containing 4′,6-diamidino-2-phenylindole (Vectashield, Vector Laboratories, Burlingame, CA), and viewed and imaged using a Leica DM6000 microscope (Leica Microsystems, Deerfield, IL).
C-3.
Comparison of CPHN cells in childhood and adults for replication (Ki67) and endocrine lineage (Nkx6.1 and Nkx2.2)-Once we established that, in contrast to adults with T1D [14] , the frequency of CPHN cells in children with T1D did not differ from control children, we then compared the frequency of replication of CPHN (by Ki67) cells and the expression of the transcription factors Nkx6.1 and Nkx2.2 between adults and children. To do so, we included four adult donors with T1D (case IDs 6138, 6051, 6076, and 6050) and four without (case IDs 6015, 6021, 6029, and 6134) in which we previously reported the frequency of Ki67, Nkx6.1 and Nkx2.2 in CPHN cells [14] . We also analyzed three additional cases of adult T1D (case IDs 6036, 6045, and 6068) and adult ND (case IDs 6012, 6126, and 6104) for these same nuclear markers and compared the data with the selected subset of T1D and ND children (children with T1D, n = 6; ND children, n = 6; adults with T1D, n = 7; ND adults, n = 7).
D. Morphometric Analysis
One section of pancreas per subject was stained. Endocrine cells from 50 islets, as well as all endocrine cells present as single cells or in clusters in the exocrine pancreas contained within those islet-containing fields per subject were imaged at ×20 magnification. An islet was defined as a grouping of four or more endocrine cells. A cluster was defined as a grouping of three or fewer chromogranin-positive cells. Islets were selected by starting at the top left corner of the pancreatic tissue section and working across the tissue from left to right and back again in a serpentine fashion, imaging all islets in this systematic excursion across the tissue section. Analysis was performed in a blinded fashion by four of the authors (A.S.M.M., M.C., A.O., and J.C.), and all CPHN cells identified were confirmed by a second observer (A.E.B.). The endocrine cells contained within each islet were manually counted and recorded as follows: (1) the number of cells staining for chromogranin A; (2) the number of cells staining for the endocrine hormone cocktail; and (3) the number of cells staining for insulin. Thus, cells staining for chromogranin A but not the other known pancreatic hormones (i.e., insulin, glucagon, somatostatin, pancreatic polypeptide, or ghrelin) were noted.
At ×200 magnification, using the Leica DM6000 with Hamamatsu Orca-ER camera and a ×0.7 C-mount, each field of view was calculated to be 0.292 mm 2 . Within the fields imaged to obtain the 50 islets per subject, all single endocrine cells and clusters of endocrine cells (two or three adjacent endocrine cells) were counted and recorded as described in the previous paragraph.
E. Statistical Analysis
Statistical analysis was performed using the Student t test with GraphPad Prism 6.0 software (GraphPad Software, La Jolla, CA). Data in graphs and tables are presented as means ± standard error of the mean. Findings were assumed statistically significant at P < 0.05.
F. Study Approval
These studies in humans were reviewed and approved by the institutional review boards of the University of Florida and the University of California, Los Angeles. Informed consent was not required because the subjects were brain-dead organ donors.
Results

A. CPHN Cells Did Not Occur More Frequently in Children With T1D Than in ND Control Subjects
The mean number of endocrine cells counted within islets for the children with There was no increase in the frequency of CPHN cells in children with T1D compared with ND children (1.4% ± 0.2% vs 1.0% ± 0.2% of endocrine cells, T1D vs ND groups, respectively; P = ns), in either islets or scattered cells, or in(islets and clusters combined [ Fig. 1(e) ].
B. Replication of CPHN Cells in Children and Adults With T1D
CPHN cells expressing Ki67 were identified in pancreas tissue of children with T1D and ND children (Fig. 2) at a comparable frequency (5.5% ± 2.0% vs 6.3% ± 2.7% of Ki67-positive CPHN cells in all compartments, T1D vs ND groups, respectively; P = ns). The frequency of replication of CPHN cells was higher in children with T1D and ND children compared with either adult group. Therefore, as has previously been reported for β cells [18] , CPHN cells also have a greater capacity for replication in children than adults. The frequency of CPHN replication for T1D children and T1D adults was 5.5% ± 2.0% in children vs 0.7% ± 0.5% in adults of Ki67-positive CPHN cells relative to the total number of CPHN cells in all compartments (P < 0.05). The frequencies of CPHN replication for ND children and ND adults was 6.3% ± 2.7% and 1.1% ± 0.5%, respectively, of Ki67-positive CPHN cells relative to the total number of CPHN cells in all compartments [P < 0.05; Fig. 2(c) ]. The percentage of pancreatic CPHN cells expressing NKx6.1 in children with T1D was comparable to ND control subjects (3.0% ± 1.3% vs 1.5% ± 1.5% of NKx6.1-positive CPHN cells in all compartments, T1D vs ND groups, respectively; P = ns; Fig. 3 ). This, again, differed from the findings in adults with T1D, in whom there was a sixfold increase in the percentage of CPHN cells that expressed NKx6.1 compared with ND organ donors [20.0% ± 6.0% vs 3.4% ± 1.7% of NKx6.1-positive CPHN cells of total CPHN cells, T1D vs ND adult groups, respectively; P < 0.05; Fig. 3(c) ].
C. CPHN Cells With a Potential
Nkx2.2 marks multipotent pancreatic progenitors, but, unlike mouse pancreas, it is detected in human pancreas progenitors after endocrine commitment [19] . There was no difference in the frequency of pancreatic CPHN cells expressing NKx2.2 in children with T1D vs ND control subjects (75.3% ± 11.2% vs 80.2% ± 5.0% of NKx2.2-positive CPHN, T1D vs ND children groups, respectively; P = ns; Fig. 4) . However, the frequency of NKx2.2-positive CPHN cells was lower in T1D and ND children compared with T1D and ND adult donors [75.3% ± 11.2% vs 96.1% ± 2.5% in children with T1D vs adults with T1D, respectively; and 80.2% ± 5.0% vs 94.4% ± 4.3%, ND children vs ND adults, respectively, of NKx2.2-positive CPHN cells of total CPHN cells in all compartments; P < 0.05 in both comparisons; Fig. 4(c) ].
Discussion
We found no increase in frequency in pancreatic endocrine cells expressing no known pancreatic hormone in children with T1D. This is in notable contrast to the marked increase in these CPHN cells in adults with T1D [14] . Several possibilities could account for this difference.
First, it is possible that, in adults, rather than CPHN cells being newly formed endocrine cells, they could be endocrine cells undergoing dedifferentiation secondary to metabolic or autoimmune stress. However, the location of the increased CPHN cells in adults with T1D, largely found as scattered cells or small foci in the exocrine pancreas rather than in established islets, weighs against dedifferentiation of mature endocrine cells. Indeed, the distribution of the more frequent CPHN cells in adults with T1D closely resembles that in the newly forming endocrine pancreas in late gestation and early infancy [10] .
A second possibility is that the mechanism of neogenesis in production of new endocrine cells in the pancreas is more robust in adults than in children. Expansion of the β-cell mass in young children is mediated through replication of existing β cells, and so plausibly any effort at β-cell regeneration might seek that route. In contrast, in adult humans, β-cell replication is rare and perhaps the increased foci of CPHN cells in adults with T1D reveals attempted so-called neogenesis of endocrine cells from as-yet uncharacterized putative precursors [18] .
A third possibility for the lack of increased CPHN cells in children with T1D compared with ND children is the increased replication of these cells in children compared with adults [18] . Replicating cells exposed to any DNA modifying stress are more vulnerable to apoptosis through failure of cell cycle checkpoints compared with cells in G 0 ; therefore, it is plausible that any effort to enhance formation of new CPHN cells in childhood T1D is countered by enhanced apoptosis of these cells in the proximity of autoimmune-mediated stress [20] .
Replication of most cell types is more frequent in childhood when compared with adults. Therefore, our finding that CPHN-cell replication was higher in children, regardless of diabetic status, when compared with adults is not surprising.
However, it is notable that although, in adults, the percentage of Nkx6.1-positive CPHN cells was raised in T1D, this was not the case in childhood T1D. Autoimmune-mediated destruction of β cells is more rapid in children than adults with T1D, implying more robust autoreactivity [6] . Given the epitope-spreading characteristic of autoimmunity and that Nkx6.1-positive CPHN cells are fated to a β-cell lineage, one might reasonably expect a more rapid clearance of Nkx6.1-expressing CPHN cells in children than in adults with T1D.
Another possibility is that inflammatory mediators could be preventing β-cell differentiation by inhibiting the transcription factors that preserve a mature β-cell phenotype [21] ; as noted, the immune assault and local inflammation may be more intense in the children with T1D. Although children, regardless of diabetic status, had a lower percentage of Nkx2.2-positive CPHN cells than adults, the differences were much less marked than those seen with the percentage of Nkx6.1-positive CPHN cells, raising the possibility that, in children, Nkx2.2 cells are prevented from differentiating further into Nkx6.1-positive cells as a consequence of the more intense inflammatory milieu.
Conclusion
In summary, pancreatic CPHN cells were comparable in abundance in children with T1D and ND children. This finding differs from the increased frequency of these cells in adults with T1D, as does the lower frequency of CPHN cells expressing NK6.1 in children with T1D compared with control subjects. The importance of characterizing pancreatic changes in both children and adults with T1D is again emphasized because the pattern and progression of T1D differs markedly between these age groups and, therefore, effective strategies to intervene most likely also differ. Table 1 Characteristics of Patients With T1D 
